Scilex Holding Company Cost of Revenue
Scilex Holding Company (SCLX) reported Cost of Revenue of $8.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-14
- Scilex Holding Company cost of goods and services sold for the quarter ending 2026-06-30 was $8.12M, a 72.61% decline year-over-year.
- Scilex Holding Company cost of goods and services sold for the quarter ending 2026-03-31 was $17.12M, a 34.82% increase year-over-year.
- Scilex Holding Company cost of goods and services sold for the quarter ending 2025-06-30 was $29.64M.
- Scilex Holding Company cost of goods and services sold for the quarter ending 2025-03-31 was $12.70M.
- Scilex Holding Company cost of goods and services sold for fiscal 2025 was $96.26M, a 13.16% decline from fiscal 2024.
- Scilex Holding Company cost of goods and services sold for fiscal 2024 was $110.85M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|
| 2026-06-30 | $8.12M 10-Q · filed 2026-08-14 | $25.24M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $17.12M 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | $96.26M 10-K · filed 2026-04-10 | ||
| 2025-06-30 | $29.64M 10-Q · filed 2026-08-14 | $42.34M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $12.70M 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | $110.85M 10-K · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |